1,341
Views
13
CrossRef citations to date
0
Altmetric
Original Research Article

Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners

ORCID Icon, , , , &
Pages 303-308 | Received 21 Mar 2018, Accepted 01 Jul 2018, Published online: 10 Sep 2018

References

  • Guttmacher Institute [Internet]. Adding it up: investing in contraception and maternal and newborn health, 2017. 2018. Available from: www.guttmacher.org/fact-sheet/adding-it-up-contraception-mnh-2017
  • Darroch J, Sedgh G, Ball H, Contraceptive technologies: responding to women’s needs. New York (NY): Guttmacher Institute; 2011.
  • Ali M, Cleland J, Shah I, Causes and consequences of contraceptive discontinuation: evidence from 60 demographic and health surveys. Geneva: WHO; 2012.
  • Sedgh G, Ashford L, Hussain R, Unmet need for contraception in developing countries: examining women’s reasons for not using a method. New York (NY): Guttmacher Institute; 2016.
  • Halpern V, Lopez L, Grimes D, et al. Strategies to improve adherence and acceptability of hormonal methods of contraception. Cochrane Database Syst Rev. 2013;10:CD004317.
  • Joshi R, Khadilkar S, Patel M. Global trends in use of long-acting reversible and permanent methods of contraception: seeking a balance. Int J Gynaecol Obstet. 2015;131:S60–S63.
  • Bühling K, Zite N, Lotke P, et al. Worldwide use of intrauterine contraception: a review. Contraception. 2014;89:162–173.
  • Trussell J. Contraceptive failure in the United States. Contraception. 2011;83:397–404.
  • Rademacher K, Solomon M, Brett T, et al. Expanding access to a new, more affordable levonorgestrel intrauterine system in Kenya: service delivery costs compared with other contraceptive methods and perspectives of key opinion leaders. Glob Health Sci Pract. 2016;4:S83–S93.
  • Hubacher D. The levonorgestrel intrauterine system: reasons to expand access to the public sector of Africa. Glob Health Sci Pract. 2015;3:532–537.
  • Jacobstein R, Shelton J. The levonorgestrel intrauterine system: a pragmatic view of an excellent contraceptive. Glob Health Sci Pract. 2015;3:538–543.
  • Family Planning Brief [Internet]. PMA2016/Kenya-R5. 2017. Available from: www.pma2020.org/sites/default/files/KER5-2PG-FP-Indicator-Brief-v13-2017-07.14.sed_.pdf
  • Kenya National Bureau of Statistics (KNBS) and ICF Macro. Kenya demographic and health survey 2008–09. Calverton (MD): KNBS, ICF Macro; 2010.
  • Kenya National Bureau of Statistics, Ministry of Health, National AIDS Control Council. Kenya demographic and health survey 2014. Rockville (MD): ICF International; 2015.
  • FHI 360, Marie Stopes International [Internet]. Introduction of a new LNG-IUS: summary of a market assessment. 2015. Available from: www.rhsupplies.org/uploads/tx_rhscpublications/Summary-Market-Assessment-LNG-IUS-Kenya.pdf
  • Hubacher D, Masaba R, Manduku C, et al. Uptake of the levonorgestrel intrauterine system among recent postpartum women in Kenya: factors associated with decision-making. Contraception. 2013;88:97–102.
  • Hubacher D, Masaba R, Manduku C, et al. The levonorgestrel intrauterine system: cohort study to assess satisfaction in a postpartum population in Kenya. Contraception. 2015;91:295–300.
  • Nyarko P, Adohinzin C, Tapsoba P, et al. Acceptability and promotion strategies for LNG-IUS in Ghana: a public health assessment. Accra: Population Council, Regional Office for Sub-Saharan Africa; 2009.
  • Bednarek H, Jensen J. Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS. Int J Womens Health. 2010;1:45–58.
  • Lowe R, Prata N. Hemoglobin and serum ferritin levels in women using copper-releasing or levonorgestrel-releasing intrauterine devices: a systematic review. Contraception. 2013;87:486–496.
  • Castle S, Askew I, Koli Hossain S, Jain A. Contraceptive discontinuation: reasons, challenges, and solutions. FP2020, the Population Council. 2015.
  • Bryant A, Hamela G, Gotter A, et al. Reasons for intrauterine device use, discontinuation and non-use in Malawi: a qualitative study of women and their partners. Afr J Reprod Health. 2015;19:50–57.
  • Alege SG, Matovu JK, Ssensalire S, et al. Knowledge, sources and use of family planning methods among women aged 15–49 years in Uganda: a cross-sectional study. Pan Afr Med J. 2016;24:39.
  • Tumlinson K, Pence BW, Curtis SL, et al. Quality of care and contraceptive use in urban Kenya. Int Perspect Sex Reprod Health. 2015;41:69–79.
  • Ochako R, Mbondo M, Aloo S, et al. Barriers to modern contraceptive methods uptake among young women in Kenya: a qualitative study. BMC Public Health. 2015;15:118.
  • Mutumba M, Wekesa E, Stephenson R. Community influences on modern contraceptive use among young women in low and middle-income countries: a cross-sectional multi-country analysis. BMC Public Health. 2018;18:430.
  • Vouking M, Evina C, Tadenfok C. Male involvement in family planning decision making in sub-Saharan Africa- what the evidence suggests. Pan Afr Med J. 2014;19:349.
  • Moseley SF. Everett Rogers’ diffusion of innovations theory: its utility and value in public health. J Health Commun. 2004;9:149–151.